Helen Chen is Global Sector Co-Head for Healthcare and a Greater China Managing Partner of L.E.K. Consulting based in Shanghai. Helen was a member of L.E.K.’s Global Leadership Team from 2012 to 2016. She is also a Director of the firm’s Asia-Pacific Life Sciences Centre of Excellence. Helen was named one of Consulting magazine’s Global Leaders in Consulting in 2019.

Helen has over 30 years of consulting and industry experience in the U.S. and Asia markets and has lived in China since 2000. She helps companies expand their presence in China and Asia, and leverages Asia’s innovation to improve their global businesses. For companies anchored in China, Helen advises on their drive to innovation and globalization. Helen is a frequent speaker and author on the opportunities and issues in China’s healthcare and life sciences sectors. Her expert commentary has appeared in Bloomberg, Financial Times, The Wall Street Journal, Forbes Asia and the South China Morning Post, and in several industry publications, including BioCentury, In Vivo, Script and BioWorld.

Prior to joining L.E.K., Helen held senior management roles at several technology companies in the U.S. and China. She was an associate director of finance at Genentech (now Roche) and a sales planner at Abbott Laboratories (now Abbvie). Helen has an honors B.A. degree in Applied Mathematics from Harvard University.

Education

Undergraduate: Bachelor of Arts with Honors, Applied Mathematics, Harvard University

Helen Chen

Helen's Expertise

Read more

Related Insights

Lung Cancer Drug Launch in the China Market - Case Study

In China, over one million people get lung cancer each year, and for six hundred thousand the disease is terminal. In one of the largest worldwide markets…
 

The Impact of Government Policies and the Trade War on China's Healthcare Industry

Helen Chen, Greater China Managing Partner at L.E.K., discusses government initiatives in China’s fast-growing healthcare industry and the impact of the U…

Navigating China's Healthcare Market

Global Collaboration Opportunities in China's Healthcare Innovation

Contrasting China's Market Dynamics with Global Pharma Giants

Lung Cancer Drug Launch
Life Sciences & Pharma

Lung Cancer Drug Launch in the China Market - Case Study

Helen-Chen-Interview-Video
Life Sciences & Pharma

The Impact of Government Policies and the Trade War on China's Healthcare Industry

Shanghai skyline
Biotech and Pharmaceuticals

Navigating China's Healthcare Market

city skyline
Healthcare Services

Global Collaboration Opportunities in China's Healthcare Innovation

city skyline
Life Sciences & Pharma

Contrasting China's Market Dynamics with Global Pharma Giants